Brendan J. Guercio Genitourinary Oncology Service, Department of Medicine, , New York, New York. Genitourinary Oncology Service, Department of Medicine,, New York, New York. Search for other works by this author on: Eugene J. Pietzak Urology Service, Department of Surgery, , New York, New York. Urology Service, Department of Surgery,, New York, New York. Search for other works by this author on: Vignesh Ravichandran Marie-Josée and Henry R. Kravis Center for Molecular Oncology, , New York, New York.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark T.A
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable Targets
We found 241 BRAF fusion–positive tumors from 212 patients with 82 unique 5′ fusion partners spanning 52 histologies. Thirty-nine fusion partners were not previously reported, and 61 were identified once. BRAF fusion incidence was enriched in pilocytic astrocytomas, gangliogliomas, low-grade neuroepithelial tumors, and acinar cell carcinoma of the pancreas. Twenty-four patients spanning multiple histologies were treated with MAPK-directed therapies, of which 20 were evaluable for RECIST.
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Citation Rohit ThummalapalliBiagio RicciutiChaitanya BandlamudiDaniel MuldoonHira RizviArielle ElkriefJia LuoJoao V. AlessiFederica PecciGiuseppe LambertiAlessandro Di FedericoLingzhi HongJianjun ZhangJohn V. HeymachDon L. GibbonsAndrew J. PlodkowskiVignesh RavichandranMark T.A. DonoghueChad VanderbiltMarc LadanyiCharles M. RudinMark G. KrisGregory J. RielyJamie E. ChaftMatthew D. HellmannNatalie I. VokesMark M. AwadAdam J.
Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License .
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License . Supplementary data
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack